Blueprint Medicines Corp (BPMC) Insider Trading

Total insider buys:
  • $348,278.00
Total insider sells:
  • $158,672,242.23
Most recent insider trade:
  • June 5, 2024
Most active insider trader:
  • Jeffrey W Albers
Trader NameDateTitleAmountPriceTypeTotal Value
June 5, 2024Insider4,000$105.13Sell$420,520.00
June 3, 2024Insider4,922$106.43Sell$523,848.46
May 31, 2024Insider34,108$105.91Sell$3,612,378.28
May 2, 2024Insider1,834$103.88Sell$190,515.92
May 2, 2024CFO10,000$105.00Sell$1,050,000.00
March 28, 2024CFO5,000$95.00Sell$475,000.00
March 20, 2024Director25,073$87.28Sell$2,188,371.44
March 15, 2024CFO13,734$87.78Sell$1,205,570.52
March 7, 2024EVP5,194$90.69Sell$471,043.86
March 7, 2024Insider3,097$90.69Sell$280,866.93
March 7, 2024CFO5,003$90.69Sell$453,722.07
March 7, 2024COO6,070$90.69Sell$550,488.30
March 7, 2024CEO12,464$90.69Sell$1,130,360.16
March 4, 2024Insider621$93.65Sell$58,156.65
Feb. 28, 2024Insider5,000$100.00Sell$500,000.00
Jan. 25, 2024Director25,000$81.91Sell$2,047,750.00
Dec. 22, 2023Insider714$90.00Sell$64,260.00
Dec. 7, 2023Insider5,000$75.00Sell$375,000.00
Dec. 4, 2023Insider600$71.43Sell$42,858.00
Nov. 30, 2023Director5,000$70.55Sell$352,750.00
Nov. 24, 2023Director15,000$67.51Sell$1,012,650.00
Nov. 3, 2023Director1,485$60.13Sell$89,293.05
Nov. 1, 2023Director3,881$60.02Sell$232,937.62
Oct. 26, 2023Insider600$56.40Sell$33,840.00
Oct. 4, 2023Insider3,769$48.06Sell$181,138.14
Sept. 28, 2023Director6,898$50.17Sell$346,072.66
Aug. 25, 2023Director10,000$50.16Sell$501,600.00
June 5, 2023Insider2,307$52.06Sell$120,102.42
March 6, 2023Director9,793$45.67Sell$447,246.31
March 6, 2023Insider1,875$45.68Sell$85,650.00
March 6, 2023COO3,059$45.67Sell$139,704.53
March 6, 2023EVP3,322$45.68Sell$151,748.96
March 6, 2023CFO3,007$45.68Sell$137,359.76
March 6, 2023CEO6,640$45.69Sell$303,381.60
Dec. 5, 2022Director20,000$50.09Sell$1,001,800.00
Nov. 3, 2022CEO1,100$43.98Buy$48,378.00
Nov. 3, 2022COO533$45.24Sell$24,112.92
Oct. 4, 2022Insider3,477$67.30Sell$234,002.10
Aug. 24, 2022Insider5,000$75.11Sell$375,550.00
Aug. 22, 2022Director8,410$70.54Sell$593,241.40
Aug. 19, 2022Director1,590$70.02Sell$111,331.80
Aug. 16, 2022Director20,000$68.41Sell$1,368,200.00
Aug. 8, 2022Director10,000$70.07Sell$700,700.00
Aug. 4, 2022SVP2,500$60.44Sell$151,100.00
June 6, 2022Insider1,908$59.76Sell$114,022.08
April 6, 2022CEO5,000$70.11Sell$350,550.00
March 16, 2022Insider2,219$60.00Sell$133,140.00
March 10, 2022Insider2,339$57.15Sell$133,673.85
March 7, 2022Insider256$56.19Sell$14,384.64
March 3, 2022Director5,000$59.98Buy$299,900.00
First«1 of 4»Last
  • Insiders are both buying and selling Blueprint Medicines Corp stock.

  • The insider traders at Blueprint Medicines Corp are: Jeffrey W Albers, Ariel Hurley, Kate Haviland, Daniel Lynch, Christopher K Murray, L. Becker Hewes, Anthony L Boral, Nicholas Lydon, George Demetri, Marion Dorsch, Tracey L Mccain, Fmr Llc, Michael Landsittel, Mark Alan Goldberg, Christoph Lengauer, Christina Rossi, Fouad Namouni, Percy H Carter, Debra Durso-Bumpus, Charles A Rowland Jr, Alexis Borisy, Kevin P. Starr, Lonnel Coats, Rock Ventures Ii L.P. Third, and Mark J Levin

  • The most active insider trader at Blueprint Medicines Corp is Jeffrey W Albers with 38 trades.

  • Rock Ventures Ii L.P. Third has sold the most Blueprint Medicines Corp stock with a total value of $70,560,000.00.

  • Mark Alan Goldberg has bought the most Blueprint Medicines Corp stock with a total value of $599,800.00.

  • The most recent insider trade for Blueprint Medicines Corp was on June 5, 2024.

  • The single biggest insider buy for Blueprint Medicines Corp was from Mark Alan Goldberg with a total value of $299,900.00 on March 3, 2022.

  • The single biggest insider sell for Blueprint Medicines Corp was from Rock Ventures Ii L.P. Third with a total value of $35,280,000.00 on Feb. 7, 2017.